Recombinant IL7RA (Lusvertikimab Biosimilar) antibody

Catalog No. ABIN7490916

This Humanized Monoclonal antibody specifically detects IL7RA (Lusvertikimab Biosimilar) in FACS. It exhibits reactivity toward Human.

Quick Overview for Recombinant IL7RA (Lusvertikimab Biosimilar) antibody (ABIN7490916)

Target: IL7RA (Lusvertikimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This IL7RA (Lusvertikimab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS)

Grade: Research Grade

Product Details anti-IL7RA (Lusvertikimab Biosimilar) Antibody

Purpose: Anti-IL7RA (lusvertikimab biosimilar) mAb

Characteristics: Effi-7,Effi7-h,MD-707

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG4

Application Details

Application Notes: Flow Cyt 1:100

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for IL7RA (Lusvertikimab Biosimilar)

Target: IL7RA (Lusvertikimab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: CD127, CDW127, IL-7R-alpha, IL7RA, ILRA

UniProt: P16871